Palo Alto Veterans Affairs
Palo Alto, California, 94304, United States
NCT Number: NCT02006095
Carotid revascularization can significantly reduce the risk of stroke in patients with severe carotid stenosis; however, it has been associated with cognitive decline in 25% of the older adults who undergo the procedure. Characterizing risk factors for cognitive decline following carotid interventions and individualizing treatment strategy based on those risks can minimize procedure-associated cognitive dysfunction. Neuroimaging techniques that characterize white matter integrity and regional hypoperfusion have the potential to provide sensitive brain structure indicators that may be associated with memory decline following revascularization procedures. In this protocol, we hope to determine how cerebral blood flow and baseline white matter abnormality in the vulnerable region modify the frequency and cognitive effect of microembolization following carotid revascularization procedures.
Looking for future studies?
Notify Me40 year and older
All sexes
Observational
Palo Alto, California, 94304, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
arterial spin labeling, diffusion tensor imaging, and diffusion weighted imaging sequences will be used
Time frame: 6 months following the procedure
White matter abnormality and perfusion in correlation with microembolization and cognitive change
Stanford University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06935279
Arterial Occlusive Diseases, Arteriosclerosis
Xian, Shanxi, China
View Trial DetailsNCT07204678
Arterial Occlusive Diseases, Brain Diseases
Tulln, Austria
View Trial DetailsNCT06033963
Arterial Occlusive Diseases, Brain Diseases
Changchun, Jilin, China
View Trial DetailsNCT05117515
Arterial Occlusive Diseases, Brain Diseases
Düsseldorf, North Rhine-Westphalia, Germany
View Trial Details